|Other Names||Translationally-controlled tumor protein, TCTP, Fortilin, Histamine-releasing factor, HRF, p23, TPT1|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP8505c was selected from the Center region of human TPT1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Involved in calcium binding and microtubule stabilization.|
|Tissue Location||Found in several healthy and tumoral cells including erythrocytes, hepatocytes, macrophages, platelets, keratinocytes, erythroleukemia cells, gliomas, melanomas, hepatoblastomas, and lymphomas. It cannot be detected in kidney and renal cell carcinoma (RCC). Expressed in placenta and prostate.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
TPT1 is involved in calcium binding and microtubule stabilization.
Choi,S., et.al., PLoS ONE 4 (6), E5732 (2009)Sanchez,J.C., et.al., Electrophoresis 18 (1), 150-155 (1997)
If you have any additional inquiries please email technical services at email@example.com.